24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Molecular and biochemical basis <strong>of</strong> disease<br />

(1989) .Family History, Electroencephalography (EEG) recordings and<br />

CT Scan were obtained from most patients . The study was approved<br />

by the Iranian institutional ethics committees . DNA was obtained from<br />

50 unrelated families with idiopathic generalized epilepsy as index<br />

families . The 26 exons <strong>of</strong> SCNIA were Screened for deletions and duplications<br />

by MLPA. In order to finding point mutations and SNPs each<br />

exon individually amplified from genomic DNA in PCR reactions using<br />

intronic primers and were analyzed by Single Strand conformation<br />

Polymorphism gel electrophoresis (SSCP) and conformation-sensitive<br />

gel electrophoresis(CSGE) and so the PCR products with mobility variants<br />

were sequenced by ABI sequencer. We have identified some new<br />

intronic variants in SCNIA and new mutations too, in patients with IGE<br />

subtypes .<br />

Allele and genotype frequencies in the patients and in the control<br />

groups were compared Statisticaly<br />

P05.096<br />

molecular genetic analysis <strong>of</strong> SCN B gene in Russian patients<br />

with idiopathic ventricular arrhythmias<br />

E. Ivanova1 , H. Zaklyazminskaya2 ;<br />

1Russian Research Center for Medical <strong>Genetics</strong>, Moscow, Russian Federation,<br />

2Center <strong>of</strong> Molecular <strong>Genetics</strong>, Odintsovo, Russian Federation.<br />

Cardiac channelopathies is a new class <strong>of</strong> diseases characterized by<br />

high risk <strong>of</strong> life-threatening arrhythmias and sudden cardiac death with<br />

apparently normal heart . Mutations in more than 10 different genes<br />

can cause these diseases . For different disorders within this group<br />

approximately 25-60% patients remain genotype negative . Recently, a<br />

new gene SCN4B encoding β4-subunit <strong>of</strong> Na 1 .5 was shown in Long<br />

v<br />

QT Syndrome (LQTS) family . The aim <strong>of</strong> this work is to screen mutation<br />

in SCN4B gene in patients with idiopathic ventricular arrhythmias and<br />

to estimate the prevalence <strong>of</strong> genetic alterations in this gene in Russian<br />

patients . The DNA samples <strong>of</strong> 48 unrelated patients (mutations in<br />

KCNQ1, KCNH2, SCN5A, KCNE1 and KCNE2 had been excluded)<br />

with ventricular arrhythmias had been analyzed . Fourteen patients had<br />

LQTS, 14 patients had Brugada Syndrome (BrS) and 20 patients had<br />

Idiopathic Ventricular Tachycardia (IVT) . Molecular genetic testing was<br />

performed by PCR-SSCP analysis with following direct sequencing <strong>of</strong><br />

abnormal conformers . We did not found any disease-causing mutation<br />

in SCN4B gene . We suppose that SCN4B-associated arrhythmias are<br />

extremely rare in Russian patients with LQTS, BrS and IVT . Polymorphism<br />

c . C174T (p . C58C) in exon 2 was found within group <strong>of</strong> patients<br />

with BrS . The prevalence <strong>of</strong> this SNP among the patients with BrS<br />

and control group (100 unrelated unaffected individuals) was about<br />

7% without significant differences. Thus, it’s unlikely that c. C174C can<br />

significantly modify Na + -channel function . By now, routine analysis <strong>of</strong><br />

SCN4B gene for patients without mutations in KCNQ1, KCNH2, SC-<br />

N5A, KCNE1 and KCNE2 seems to be inexpedient .<br />

P05.097<br />

CS expression in infertile men correlates with the efficiency <strong>of</strong><br />

the spermatogenic process<br />

S. Bonache1 , E. Terribas1 , J. Sánchez2 , L. Bassas2 , S. Larriba1 ;<br />

1Medical and Molecular <strong>Genetics</strong> Center-Fundació IDIBELL, BARCELONA,<br />

Spain, 2Andrology Service-Fundació Puigvert, BARCELONA, Spain.<br />

Germ cells use mitochondrial Krebs cycle (KC)/electron transport system<br />

and glycolysis for the maintenance <strong>of</strong> their ATP concentration, but<br />

each stage <strong>of</strong> spermatogenesis rely on one or other pathway for ATP<br />

production . Interestingly, spermatocytes and spermatids RNA and protein<br />

synthesis is highly dependent on mitochondria as the major ATP<br />

supplier .<br />

Citrate synthase (CS) is the first enzyme in the KC. We have assessed<br />

the role <strong>of</strong> KC in the progression <strong>of</strong> spermatogenesis by the CS gene<br />

expression analysis in testicular biopsies <strong>of</strong> 39 non-obstructive and<br />

20 obstructive infertile men. Samples were classified into four groups,<br />

from 1 (total absence <strong>of</strong> germ cells) to 4 (conserved spermatogenesis),<br />

on the basis <strong>of</strong> the Johnsen score count .<br />

The current method has been the real time RT-PCR [LightCycler<br />

Instrument (Roche) and SYBR Green I fluorescence dye] and the<br />

relative quantification strategy, using cyclophilin-A as an endogenous<br />

control gene . The Mann-Whitney U test was used to analyse gene<br />

expression differences between groups .<br />

CS transcript levels positively correlated with all germ cell stages number<br />

but a negative correlation was found with Sertoli cells supporting<br />

the greater contribution <strong>of</strong> germ cells to CS transcription . Transcript<br />

levels <strong>of</strong> CS were significantly decreased in spermatogenic failure-affected-samples<br />

(p=0.01), suggesting to play a role in the efficiency <strong>of</strong><br />

spermatogenesis. Additionally, its significant correlation with the elongated<br />

spermatid number may indicate that CS has an active transcription<br />

in the latest stages <strong>of</strong> spermatogenesis with potential implications<br />

in the metabolic activity <strong>of</strong> sperm .<br />

Supported by FIS (PI02/0120, PI05/0759, CP03/00088, CA06/0055)<br />

P05.098<br />

Differential susceptibility <strong>of</strong> imprinting centers to epimutations<br />

under DNA demethylation influence<br />

E. A. Sazhenova1 , I. N. Lebedev1 , A. V. Eremeev2 , A. V. Svetlakov2 ;<br />

1 2 Institute <strong>of</strong> Medical <strong>Genetics</strong>, Tomsk, Russian Federation, Center <strong>of</strong> Reproductive<br />

Medicine, Krasnoyarsk, Russian Federation.<br />

Genomic imprinting is an epigenetic phenomenon, which is involved in<br />

regulation <strong>of</strong> embryonic development, placental function and neurobehavioural<br />

processes . Changes in differential methylation <strong>of</strong> imprinting<br />

control (IC) regions are one <strong>of</strong> the possible mechanisms leading to<br />

aberrant gene inactivation or loss <strong>of</strong> imprinting associated with some<br />

hereditary diseases and cancer . However, incidence <strong>of</strong> epimutations<br />

in different imprinted loci as well as underlined mechanisms <strong>of</strong> its arising<br />

remains elusive . Previously we have reported about differential<br />

susceptibility to epimutations <strong>of</strong> three IC’s in spontaneous abortions<br />

and described the loss <strong>of</strong> methylation <strong>of</strong> KCNQ1OT1 in 9 .5% <strong>of</strong> embryos<br />

. The aim <strong>of</strong> the present research was analysis <strong>of</strong> methylation<br />

stability <strong>of</strong> previously investigated IC’s (SNURF-SNRPN, H19/IGF2,<br />

KCNQ1OT1) under influence <strong>of</strong> DNA demethylating agent such as 5aza-2-deoxycytidine<br />

in vitro. Fetal fibroblasts cell cultures from 17 induced<br />

abortions (9 .6±0 .2 weeks <strong>of</strong> pregnancy) with normal karyotype<br />

were treated by 5-aza-2dC with 5 μg/ml for 72 h. Methylation analysis<br />

was performed by methyl-specific or methylation-sensitive PCR. A normal<br />

differential methylation <strong>of</strong> SNURF-SNRPN and H19/IGF2 was observed<br />

in all cell cultures after 5-aza-2dC treatment . As to KCNQ1OT1,<br />

all cell cultures have revealed a loss <strong>of</strong> methylation in maternal allele<br />

. Loss <strong>of</strong> imprinting in KCNQ1OT1 was observed in our previous<br />

research <strong>of</strong> spontaneous abortions as well as in most children born<br />

after IVF procedures with Beckwith-Wiedemann syndrome reported in<br />

literature . Our results indicate a different susceptibility <strong>of</strong> IC’s to epimutations,<br />

providing evidence for KCNQ1OT1 as a «hot spot» <strong>of</strong> aberrant<br />

epigenetic modifications in the human genome.<br />

P05.099<br />

Infantile neuroaxonal dystrophy: challenges for identification<br />

and new advances in prenatal diagnosis<br />

W. Lissens 1 , G. Buyse 2 , J. Misson 3 , L. Lagae 2 , C. Ceuterick-De Groote 4 , R. Van<br />

Coster 5 , E. Schmedding 1 , S. Seneca 1 , L. De Meirleir 1 ;<br />

1 University Hospital UZ Brussel, Brussels, Belgium, 2 University Hospitals K.U.<br />

Leuven, Leuven, Belgium, 3 CHU Sart-Tilman, Liège, Belgium, 4 Born-Bunge<br />

Institute, Antwerp, Belgium, 5 University Hospital Ghent, Ghent, Belgium.<br />

Infantile neuroaxonal dystrophy (INAD; OMIM #256600) is a rare disease<br />

belonging to the group <strong>of</strong> neurodegenerative disorders together<br />

with NBIA (neurodegeneration with brain iron accumulation, PANK2<br />

gene, OMIM #234200), KARAK syndrome and Schindler disease<br />

(OMIM #609241) . These diseases share the pathologic feature <strong>of</strong> axonal<br />

degeneration with distended axons throughout the central nervous<br />

system . In previous work there has been some controversy regarding<br />

whether INAD is a separate entity or is part <strong>of</strong> a spectrum <strong>of</strong> diseases<br />

with panhothenate kinase-associated neurodegeneration (PANK) .<br />

Based on molecular studies <strong>of</strong> the PANK2 gene it became clear that<br />

INAD and PANK are genetically heterogeneous disorders . Recently,<br />

a gene PLA2G6, encoding a phospholipase A2, has been recognized<br />

as causing INAD . However, there is still some overlap in phenotypes<br />

resulting from deficiencies in the PLA2G6 and PANK2 genes. We present<br />

here the clinical features, diagnosis and molecular results <strong>of</strong> four<br />

patients from three unrelated families in whom a definitive diagnosis<br />

could be made by molecular analysis .<br />

In all four patients clinical data and biochemical studies were in agreement<br />

with a diagnosis <strong>of</strong> neuroaxonal dystrophy . Molecular studies <strong>of</strong><br />

the PLA2G6 were performed to confirm this diagnosis. The two male<br />

siblings from family 1 were homozygous for a p .Val371Met substitution;<br />

there was no apparent consanguinity in this family . A healthy carrier<br />

female was born after prenatal diagnosis through chorionic villus<br />

0

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!